7-1436770-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182924.4(MICALL2):c.2563G>T(p.Val855Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000106 in 1,607,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182924.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MICALL2 | NM_182924.4 | c.2563G>T | p.Val855Leu | missense_variant | 15/17 | ENST00000297508.8 | NP_891554.1 | |
MICALL2 | XM_047420838.1 | c.1330G>T | p.Val444Leu | missense_variant | 9/11 | XP_047276794.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MICALL2 | ENST00000297508.8 | c.2563G>T | p.Val855Leu | missense_variant | 15/17 | 1 | NM_182924.4 | ENSP00000297508 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000146 AC: 35AN: 240296Hom.: 0 AF XY: 0.000145 AC XY: 19AN XY: 131134
GnomAD4 exome AF: 0.000105 AC: 153AN: 1455590Hom.: 0 Cov.: 31 AF XY: 0.000106 AC XY: 77AN XY: 724218
GnomAD4 genome AF: 0.000112 AC: 17AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2023 | The c.2563G>T (p.V855L) alteration is located in exon 15 (coding exon 15) of the MICALL2 gene. This alteration results from a G to T substitution at nucleotide position 2563, causing the valine (V) at amino acid position 855 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at